CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES
The present invention relates to novel cycloalkyl-hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, Syndrome X, thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
1 - 57 . (canceled)
58 . A method of decreasing LDL levels in a patient having hypercholesterolemia or cardiovascular disease, comprising administering to the patient a therapeutically effective amount of a compound of formula I:
or a pharmaceutically acceptable salt, wherein:
(a) each occurrence of m is independently an integer ranging from 0 to 5;
(b) each occurrence of n is independently an integer ranging from 3 to 7;
(c) X is (CH 2 ) z or Ph, wherein z is an integer from 0 to 4;
(d) R 1 and R 2 and the carbon to which they are both attached are taken together to form a (C 3 -C 7 )cycloalkyl group;
(e) each occurrence of R 11 and R 12 and the carbon to which they are both attached are taken together to form a (C 3 -C 7 )cycloalkyl group; and
(f) each occurrence of Y 1 and Y 2 is independently COOH, COOR 3 , SO 3 H,
wherein:
(i) R 3 is (C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, phenyl, or benzyl and is unsubstituted or substituted with one or more halo, OH, (C 1 -C 6 )alkoxy, or phenyl groups, and
(ii) each occurrence of R 4 is independently H, (C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, or (C 2 -C 6 )alkynyl and is unsubstituted or substituted with one or two halo, OH, C 1 -C 6 alkoxy, or phenyl groups.
59 . The method claim 58 , wherein each occurrence of Y 1 and Y 2 is independently COOR 3 or COOH.
60 . The method of claim 58 , wherein Y 1 and Y 2 are each COOH.
61 . The method of claim 58 , wherein m is 0.
62 . The method of claim 58 , wherein m is 1.
63 . The method of claim 58 , wherein n is 4.
64 . The method of claim 58 , wherein n is 5.
65 . The method of claim 58 , wherein X is (CH 2 ) z and z is 0.
66 . The method of claim 58 , wherein the compound is
or a pharmaceutically acceptable salt thereof.
67 . The method of claim 58 , wherein the compound is
68 . The method of claim 58 , wherein the compound of formula I is orally administered to the patient in the form of a pharmaceutical composition comprising the compound of formula I, and a pharmaceutically acceptable vehicle.
69 . A method of decreasing LDL levels in a patient having hypercholesterolemia or cardiovascular disease, comprising administering to the patient a therapeutically effective amount of a compound of formula I, wherein formula I is represented by:
or a pharmaceutically acceptable salt thereof.
70 . The method of claim 69 , wherein the compound is
71 . The method of claim 69 , wherein the compound of formula I is orally administered to the patient in the form of a pharmaceutical composition comprising the compound of formula I, and a pharmaceutically acceptable vehicle.
72 . The method of claim 70 , wherein the compound is orally administered to the patient in the form of a pharmaceutical composition comprising the compound, and a pharmaceutically acceptable vehicle.